The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[(9-Isopropyl-2-piperazin-1-yl-9H-purin-6-ylamino)-methyl]-6-methoxyphenol ID: ALA2349191
PubChem CID: 71579158
Max Phase: Preclinical
Molecular Formula: C20H27N7O2
Molecular Weight: 397.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(CNc2nc(N3CCNCC3)nc3c2ncn3C(C)C)c1O
Standard InChI: InChI=1S/C20H27N7O2/c1-13(2)27-12-23-16-18(22-11-14-5-4-6-15(29-3)17(14)28)24-20(25-19(16)27)26-9-7-21-8-10-26/h4-6,12-13,21,28H,7-11H2,1-3H3,(H,22,24,25)
Standard InChI Key: WNGBFCDSTYVCFL-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
20.5112 -6.3371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2987 -6.5870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5112 -5.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7946 -6.7496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2987 -5.2497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0821 -5.5080 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0821 -6.3371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7946 -5.0955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7862 -5.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7863 -4.2706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3614 -6.7496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5570 -7.3745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5070 -3.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4988 -3.0373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9987 -7.9870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3611 -7.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7821 -2.6373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2070 -2.6249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1986 -1.8082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7737 -1.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4862 -1.3999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0729 -3.0586 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0570 -1.4040 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0524 -0.5790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6439 -6.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9253 -6.7384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9178 -7.5691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6352 -7.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3601 -7.5788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 2 0
5 3 1 0
6 7 2 0
7 4 1 0
8 3 2 0
9 2 1 0
10 8 1 0
11 7 1 0
12 2 1 0
13 10 1 0
14 13 1 0
15 12 1 0
16 12 1 0
17 14 2 0
18 14 1 0
19 18 2 0
20 17 1 0
21 19 1 0
8 6 1 0
9 5 2 0
20 21 2 0
17 22 1 0
20 23 1 0
23 24 1 0
11 25 1 0
11 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.48Molecular Weight (Monoisotopic): 397.2226AlogP: 2.14#Rotatable Bonds: 6Polar Surface Area: 100.36Molecular Species: BASEHBA: 9HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.73CX Basic pKa: 8.65CX LogP: 2.03CX LogD: 0.97Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.58Np Likeness Score: -0.91
References 1. Zatloukal M, Jorda R, Gucký T, Řezníčková E, Voller J, Pospíšil T, Malínková V, Adamcová H, Kryštof V, Strnad M.. (2013) Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases., 61 [PMID:22770608 ] [10.1016/j.ejmech.2012.06.036 ]